Cartilage Oligomeric Matrix Protein is Involved in Human Limb Development and in the Pathogenesis of Osteoarthritis

Overview

Journal Arthritis Res Ther

Publisher Biomed Central

Specialty Rheumatology

Date 2006 Mar 18

PMID 16542502

Citations 33

Authors

Sebastian Koelling

Till Sebastian Clauditz

Matthias Kaste

Nicolai Miosge

Affiliations

Soon will be listed here.

Abstract

As a member of the thrombospondin gene family, cartilage oligomeric protein (COMP) is found mainly in the extracellular matrix often associated with cartilage tissue. COMP exhibits a wide binding repertoire and has been shown to be involved in the regulation of chondrogenesis in vitro. Not much is known about the role of COMP in human cartilage tissue in vivo. With the help of immunohistochemistry, Western blot, in situ hybridization, and real-time reverse transcription-polymerase chain reaction, we aimed to elucidate the role of COMP in human embryonic, adult healthy, and osteoarthritis (OA) cartilage tissue. COMP is present during the earliest stages of human limb maturation and is later found in regions where the joints develop. In healthy and diseased cartilage tissue, COMP is secreted by the chondrocytes and is often associated with the collagen fibers. In late stages of OA, five times the COMP mRNA is produced by chondrocytes found in an area adjacent to the main defect than in an area with macroscopically normal appearance. The results indicate that COMP might be involved in human limb development, is upregulated in OA, and due to its wide binding repertoire, could play a role in the pathogenesis of OA as a factor secreted by chondrocytes to ameliorate the matrix breakdown.

Citing Articles

Clinical and omics biomarkers in osteoarthritis diagnosis and treatment.

Deng M, Tang C, Yin L, Jiang Y, Huang Y, Feng Y J Orthop Translat. 2025; 50:295-305.

PMID: 39911590 PMC: 11795539. DOI: 10.1016/j.jot.2024.12.007.

Administration of Bisphosphonate Preparations to Mice with Mild-type Hypophosphatasia Reduces the Quality of Spontaneous Locomotor Activity.

Nakamura-Takahashi A, Ishizuka S, Hirai K, Matsunaga S, Kasahara N, Shintani S Calcif Tissue Int. 2025; 116(1):30.

PMID: 39789326 PMC: 11717816. DOI: 10.1007/s00223-024-01326-w.

Integrative analyses of mendelian randomization and bioinformatics reveal casual relationship and genetic links between COVID-19 and knee osteoarthritis.

Zheng X, Li J, Ma Q, Gong J, Pan J BMC Med Genomics. 2025; 18(1):2.

PMID: 39748395 PMC: 11697936. DOI: 10.1186/s12920-024-02074-4.

Does Chronic Pancreatitis in Growing Pigs Lead to Articular Cartilage Degradation and Alterations in Subchondral Bone?.

Tomaszewska E, Hulas-Stasiak M, Dobrowolski P, Swiatkiewicz M, Muszynski S, Tomczyk-Warunek A Int J Mol Sci. 2024; 25(4).

PMID: 38396667 PMC: 10888541. DOI: 10.3390/ijms25041989.

Effects of Etanercept and Adalimumab on Serum Levels of Cartilage Remodeling Markers in Women with Rheumatoid Arthritis.

Szeremeta A, Jura-Poltorak A, Zon-Giebel A, Olczyk K, Komosinska-Vassev K J Clin Med. 2023; 12(16).

PMID: 37629227 PMC: 10455345. DOI: 10.3390/jcm12165185.

References

Murphy J, Heinegard R, McIntosh A, Sterchi D, Barry F . Distribution of cartilage molecules in the developing mouse joint. Matrix Biol. 1999; 18(5):487-97. DOI: 10.1016/s0945-053x(99)00042-6. View

Liu C, Prazak L, Fajardo M, Yu S, Tyagi N, Di Cesare P . Leukemia/lymphoma-related factor, a POZ domain-containing transcriptional repressor, interacts with histone deacetylase-1 and inhibits cartilage oligomeric matrix protein gene expression and chondrogenesis. J Biol Chem. 2004; 279(45):47081-91. DOI: 10.1074/jbc.M405288200. View

Muller G, Michel A, ALTENBURG E . COMP (cartilage oligomeric matrix protein) is synthesized in ligament, tendon, meniscus, and articular cartilage. Connect Tissue Res. 2000; 39(4):233-44. DOI: 10.3109/03008209809021499. View

Collins D, MCELLIGOTT T . Sulphate (35SO4) uptake by chondrocytes in relation to histological changes in osteoarthritic human articular cartilage. Ann Rheum Dis. 1960; 19:318-30. PMC: 1007162. DOI: 10.1136/ard.19.4.318. View

Tesche F, Miosge N . New aspects of the pathogenesis of osteoarthritis: the role of fibroblast-like chondrocytes in late stages of the disease. Histol Histopathol. 2004; 20(1):329-37. DOI: 10.14670/HH-20.329. View

Kennedy J, Jackson G, Ramsden S, Taylor J, Newman W, Wright M . COMP mutation screening as an aid for the clinical diagnosis and counselling of patients with a suspected diagnosis of pseudoachondroplasia or multiple epiphyseal dysplasia. Eur J Hum Genet. 2005; 13(5):547-55. PMC: 2673054. DOI: 10.1038/sj.ejhg.5201374. View

Chen F, Thomas A, Hecht J, Goldring M, Lawler J . Cartilage oligomeric matrix protein/thrombospondin 5 supports chondrocyte attachment through interaction with integrins. J Biol Chem. 2005; 280(38):32655-61. PMC: 2896261. DOI: 10.1074/jbc.M504778200. View

Di Cesare P, Fang C, Leslie M, Tulli H, Perris R, Carlson C . Expression of cartilage oligomeric matrix protein (COMP) by embryonic and adult osteoblasts. J Orthop Res. 2000; 18(5):713-20. DOI: 10.1002/jor.1100180506. View

Sandell L, Aigner T . Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis. Arthritis Res. 2001; 3(2):107-13. PMC: 128887. DOI: 10.1186/ar148. View

10.

Thur J, Rosenberg K, Nitsche D, Pihlajamaa T, Ala-Kokko L, Heinegard D . Mutations in cartilage oligomeric matrix protein causing pseudoachondroplasia and multiple epiphyseal dysplasia affect binding of calcium and collagen I, II, and IX. J Biol Chem. 2000; 276(9):6083-92. DOI: 10.1074/jbc.M009512200. View

11.

Deere M, Rhoades Hall C, Gunning K, Lefebvre V, Ridall A, Hecht J . Analysis of the promoter region of human cartilage oligomeric matrix protein (COMP). Matrix Biol. 2001; 19(8):783-92. DOI: 10.1016/s0945-053x(00)00127-x. View

12.

Bock H, Michaeli P, Bode C, Schultz W, Kresse H, Herken R . The small proteoglycans decorin and biglycan in human articular cartilage of late-stage osteoarthritis. Osteoarthritis Cartilage. 2001; 9(7):654-63. DOI: 10.1053/joca.2001.0420. View

13.

Aigner T, McKenna L . Molecular pathology and pathobiology of osteoarthritic cartilage. Cell Mol Life Sci. 2002; 59(1):5-18. PMC: 11337501. DOI: 10.1007/s00018-002-8400-3. View

14.

Svensson L, Aszodi A, Heinegard D, Hunziker E, Reinholt F, Fassler R . Cartilage oligomeric matrix protein-deficient mice have normal skeletal development. Mol Cell Biol. 2002; 22(12):4366-71. PMC: 133870. DOI: 10.1128/MCB.22.12.4366-4371.2002. View

15.

Di Cesare P, Chen F, Moergelin M, Carlson C, Leslie M, Perris R . Matrix-matrix interaction of cartilage oligomeric matrix protein and fibronectin. Matrix Biol. 2002; 21(5):461-70. DOI: 10.1016/s0945-053x(02)00015-x. View

16.

Giannoni P, Siegrist M, Hunziker E, Wong M . The mechanosensitivity of cartilage oligomeric matrix protein (COMP). Biorheology. 2002; 40(1-3):101-9. View

17.

Kipnes J, Carlberg A, Loredo G, Lawler J, Tuan R, Hall D . Effect of cartilage oligomeric matrix protein on mesenchymal chondrogenesis in vitro. Osteoarthritis Cartilage. 2003; 11(6):442-54. DOI: 10.1016/s1063-4584(03)00055-4. View

18.

Mann H, Ozbek S, Engel J, Paulsson M, Wagener R . Interactions between the cartilage oligomeric matrix protein and matrilins. Implications for matrix assembly and the pathogenesis of chondrodysplasias. J Biol Chem. 2004; 279(24):25294-8. DOI: 10.1074/jbc.M403778200. View

19.

Sharif M, Kirwan J, Elson C, Granell R, Clarke S . Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years. Arthritis Rheum. 2004; 50(8):2479-88. DOI: 10.1002/art.20365. View

20.

Tesche F, Miosge N . Perlecan in late stages of osteoarthritis of the human knee joint. Osteoarthritis Cartilage. 2004; 12(11):852-62. DOI: 10.1016/j.joca.2004.07.004. View